Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.


News Release

 View printer-friendly version

Charles River Laboratories to Present at Credit Suisse Healthcare Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 13, 2006--Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 15th, at 1:30 p.m. MT (3:30 p.m. ET). Mr. Foster will present an overview of Charles River's business and strategic focus.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website at A webcast replay will be accessible through the same website within 24 hours after the presentation and will remain available through December 17, 2006.

CONTACT: Charles River Laboratories International, Inc.
Susan E. Hardy, 781-262-7616
Corporate Vice President, Investor Relations

SOURCE: Charles River Laboratories International, Inc.

Featured Report

2019 Annual Report (PDF)